SCHEMBL928816

SCHEMBL928816

CC(Cl)(Cl)NCc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.48
MAPT P10636 2/20 0.48
KDM4E B2RXH2 1/20 0.48
IDO1 P14902 2/20 0.44
THRB P10828 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
CYP2D6 P10635 2/20 0.43
LMNA P02545 2/20 0.43
RIPK1 Q13546 1/20 0.43
ATM Q13315 1/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
ALOX12 P18054 1/20 0.42
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
SLC6A2 P23975 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14145021 0.88 CYP3A4 (0.50) CYP3A4MAPTKDM4EIDO1THRB
SCHEMBL125129 0.81 CYP3A4 (0.52) CYP3A4MAPTKDM4EIDO1THRB
SCHEMBL2504732 0.81 IDO1 (0.48) CYP3A4MAPTKDM4EIDO1THRB
SCHEMBL11526495 0.79 RIPK1 (0.46) CYP3A4MAPTKDM4EIDO1THRB
Hydrochloric Acid SCHEMBL538794 0.79 CYP3A4 (0.56) CYP3A4MAPTKDM4EIDO1THRB
Iodide SCHEMBL4994541 0.79 CYP3A4 (0.50) CYP3A4MAPTKDM4EIDO1THRB
Water SCHEMBL13583453 0.79 CYP3A4 (0.56) CYP3A4MAPTKDM4EIDO1THRB
Bromide SCHEMBL11038149 0.79 CYP3A4 (0.50) CYP3A4MAPTKDM4EIDO1THRB
SCHEMBL5431000 0.77 IDO1 (0.50) CYP3A4MAPTKDM4EIDO1THRB
SCHEMBL19963515 0.77 CYP2D6 (0.48) CYP3A4MAPTKDM4EIDO1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173660-B2 Process for the preparation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one and salts and solvates thereof SOLVAY PHARMACEUTICALS B.V. (NL) 2012-05-08 US disclosed
US-20110003830-A1 PROCESS FOR THE PREPARATION OF 3-AMINO-8-(1-PIPERAZINYL)-2H-1-BENZOPYRAN-2-ONE AND SALTS AND SOLVATES THEREOF SOLVAY PHARMACEUTICALS B.V. (NL) 2011-01-06 US disclosed
US-7776860-B2 Process for the preparation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one and salts and solvates thereof SOLVAY PHARMACEUTICALS B.V. (NL) 2010-08-17 US disclosed
EP-1732556-B1 PROCESS FOR THE PREPARATION OF 3-AMINO-8-(1-PIPERAZINYL)-2H-1-BENZOPYRAN-2-ONE AND SALTS AND HYDRATES THEREOF SOLVAY PHARM BV (NL) 2008-03-12 EP disclosed
EP-1732556-A1 PROCESS FOR THE PREPARATION OF 3-AMINO-8-(1-PIPERAZINYL)-2H-1-BENZOPYRAN-2-ONE AND SALTS AND HYDRATES THEREOF Solvay Pharmaceuticals B.V. (NL) 2006-12-20 EP disclosed
WO-2005092338-A1 PROCESS FOR THE PREPARATION OF 3-AMINO-8-(1-PIPERAZINYL) -2H-1-BENZOPYRAN-2-ONE AND SALTS AND HYDRATES THEREOF SOLVAY PHARMACEUTICALS B.V. (NL) 2005-10-06 WO disclosed
US-20050215566-A1 Process for the preparation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one and salts and solvates thereof SOLVAY PHARMACEUTICALS B.V. 2005-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215566-A1 Process for the preparation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one and salts and solvates thereof HTR1D, HTR1A, HTR1E CYP3A4 476/4885MAPT 3258/4885KDM4E 2865/4885
US-20110003830-A1 PROCESS FOR THE PREPARATION OF 3-AMINO-8-(1-PIPERAZINYL)-2H-1-BENZOPYRAN-2-ONE AND SALTS AND SOLVATES THEREOF HTR1D, HTR1A, HTR1E CYP3A4 476/4885MAPT 3258/4885KDM4E 2865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.